# ICMNC-HF. IntraCoronary Bone Marrow MonoNuclear Cells in Heart Failure (HF) Patients

> **NCT03145402** · PHASE1,PHASE2 · UNKNOWN · sponsor: **SCARM Institute, Tabriz, Iran** · enrollment: 5 (estimated)

## Conditions studied

- Heart Failure

## Interventions

- **BIOLOGICAL:** Intracoronary injection of stem cell
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT03145402
- **Lead sponsor:** SCARM Institute, Tabriz, Iran
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-10-20
- **Primary completion:** 2021-08-28
- **Final completion:** 2021-10-02
- **Target enrollment:** 5 (ESTIMATED)
- **Last updated:** 2020-03-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03145402

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03145402, "ICMNC-HF. IntraCoronary Bone Marrow MonoNuclear Cells in Heart Failure (HF) Patients". Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/clinical/NCT03145402. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*